Status:
COMPLETED
Badalona Major Depressive Disorder Database Study
Lead Sponsor:
AstraZeneca
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective study using a data base of anonymized medical records. The purpose of the study is to examine the different therapeutic strategies for the management of patients with major depressive ...
Detailed Description
Therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care: the Badalona database study
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- An International Classification of Primary Care (ICPC-2) or DSM-IV-TR diagnosis for major depressive disorder (MDD)
- At least 8 weeks of antidepressant treatment during the identification period of 01 January 2008 - 31 December 2009
- 18 months of enrollment with medical and pharmacy records after index episode date
Exclusion
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
2260 Patients enrolled
Trial Details
Trial ID
NCT01446692
Start Date
November 1 2011
End Date
January 1 2012
Last Update
January 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Badalona, Spain